These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 11008878)

  • 21. Enantio-specific induction of apoptosis by an endogenous neurotoxin, N-methyl(R)salsolinol, in dopaminergic SH-SY5Y cells: suppression of apoptosis by N-(2-heptyl)-N-methylpropargylamine.
    Maruyama W; Boulton AA; Davis BA; Dostert P; Naoi M
    J Neural Transm (Vienna); 2001; 108(1):11-24. PubMed ID: 11261742
    [TBL] [Abstract][Full Text] [Related]  

  • 22. An endogenous dopaminergic neurotoxin, N-methyl-(R)-salsolinol, induces DNA damage in human dopaminergic neuroblastoma SH-SY5Y cells.
    Maruyama W; Naoi M; Kasamatsu T; Hashizume Y; Takahashi T; Kohda K; Dostert P
    J Neurochem; 1997 Jul; 69(1):322-9. PubMed ID: 9202326
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Increase in salsolinol level in the cerebrospinal fluid of parkinsonian patients is related to dementia: advantage of a new high-performance liquid chromatography methodology.
    Antkiewicz-Michaluk L; Krygowska-Wajs A; Szczudlik A; Romańska I; Vetulani J
    Biol Psychiatry; 1997 Sep; 42(6):514-8. PubMed ID: 9285087
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Type A monoamine oxidase is the target of an endogenous dopaminergic neurotoxin, N-methyl(R)salsolinol, leading to apoptosis in SH-SY5Y cells.
    Yi H; Akao Y; Maruyama W; Chen K; Shih J; Naoi M
    J Neurochem; 2006 Jan; 96(2):541-9. PubMed ID: 16336631
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Endogenous synthesis of N-methylsalsolinol, an analogue of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine, in rat brain during in vivo microdialysis with salsolinol, as demonstrated by gas chromatography-mass spectrometry.
    Niwa T; Maruyama W; Nakahara D; Takeda N; Yoshizumi H; Tatematsu A; Takahashi A; Dostert P; Naoi M; Nagatsu T
    J Chromatogr; 1992 Jul; 578(1):109-15. PubMed ID: 1400775
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Salsolinol, catecholamine metabolites, and visual hallucinations in L-dopa treated patients with Parkinson's disease.
    Moser A; Siebecker F; Vieregge P; Jaskowski P; Kömpf D
    J Neural Transm (Vienna); 1996; 103(4):421-32. PubMed ID: 9617786
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Neuroprotective function of R-(-)-1-(benzofuran-2-yl)-2-propylaminopentane, [R-(-)-BPAP], against apoptosis induced by N-methyl(R)salsolinol, an endogenous dopaminergic neurotoxin, in human dopaminergic neuroblastoma SH-SY5Y cells.
    Maruyama W; Yi H; Takahashi T; Shimazu S; Ohde H; Yoneda F; Iwasa K; Naoi M
    Life Sci; 2004 May; 75(1):107-17. PubMed ID: 15102525
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Endogenous dopamine-derived neurotoxins and Parkinson's disease.
    Deleu D
    Acta Neurol Belg; 1998 Dec; 98(4):319-21. PubMed ID: 9922818
    [No Abstract]   [Full Text] [Related]  

  • 29. N-methyl(R)salsolinol produces hydroxyl radicals: involvement to neurotoxicity.
    Maruyama W; Dostert P; Matsubara K; Naoi M
    Free Radic Biol Med; 1995 Jul; 19(1):67-75. PubMed ID: 7635360
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dopamine-derived endogenous 1(R),2(N)-dimethyl-6,7-dihydroxy- 1,2,3,4-tetrahydroisoquinoline, N-methyl-(R)-salsolinol, induced parkinsonism in rat: biochemical, pathological and behavioral studies.
    Naoi M; Maruyama W; Dostert P; Hashizume Y; Nakahara D; Takahashi T; Ota M
    Brain Res; 1996 Feb; 709(2):285-95. PubMed ID: 8833765
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Selective dopaminergic neurotoxicity of isoquinoline derivatives related to Parkinson's disease: studies using heterologous expression systems of the dopamine transporter.
    Storch A; Ott S; Hwang YI; Ortmann R; Hein A; Frenzel S; Matsubara K; Ohta S; Wolf HU; Schwarz J
    Biochem Pharmacol; 2002 Mar; 63(5):909-20. PubMed ID: 11911843
    [TBL] [Abstract][Full Text] [Related]  

  • 32. No increase of synthesis of (R)salsolinol in Parkinson's disease.
    Müller T; Przuntek H; Kuhn W; Baum SS; Rommelspacher H
    Mov Disord; 1999 May; 14(3):514-5. PubMed ID: 10348481
    [No Abstract]   [Full Text] [Related]  

  • 33. Dopamine-derived 1-methyl-6,7-dihydroxyisoquinolines as hydroxyl radical promoters and scavengers in the rat brain: in vivo and in vitro studies.
    Maruyama W; Dostert P; Naoi M
    J Neurochem; 1995 Jun; 64(6):2635-43. PubMed ID: 7760044
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Metabolic activation of azaheterocyclics induced dopaminergic toxicity: possible candidate neurotoxins underlying idiopathic Parkinson's disease].
    Matsubara K
    Nihon Hoigaku Zasshi; 1998 Oct; 52(5):301-5. PubMed ID: 10077975
    [TBL] [Abstract][Full Text] [Related]  

  • 35. N-methylation of dopamine-derived 6,7-dihydroxy-1,2,3,4-tetrahydroisoquinoline, (R)-salsolinol, in rat brains: in vivo microdialysis study.
    Maruyama W; Nakahara D; Ota M; Takahashi T; Takahashi A; Nagatsu T; Naoi M
    J Neurochem; 1992 Aug; 59(2):395-400. PubMed ID: 1629715
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Increased beta-carboline 9N-methyltransferase activity in the frontal cortex in Parkinson's disease.
    Gearhart DA; Collins MA; Lee JM; Neafsey EJ
    Neurobiol Dis; 2000 Jun; 7(3):201-11. PubMed ID: 10860785
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Transfection-enforced Bcl-2 overexpression and an anti-Parkinson drug, rasagiline, prevent nuclear accumulation of glyceraldehyde-3-phosphate dehydrogenase induced by an endogenous dopaminergic neurotoxin, N-methyl(R)salsolinol.
    Maruyama W; Akao Y; Youdim MB; Davis BA; Naoi M
    J Neurochem; 2001 Aug; 78(4):727-35. PubMed ID: 11520893
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Anti-apoptotic function of L-(-)deprenyl (Selegiline) and related compounds.
    Naoi M; Maruyama W; Yagi K; Youdim M
    Neurobiology (Bp); 2000; 8(1):69-80. PubMed ID: 11008879
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The clinical syndrome of striatal dopamine deficiency. Parkinsonism induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP).
    Burns RS; LeWitt PA; Ebert MH; Pakkenberg H; Kopin IJ
    N Engl J Med; 1985 May; 312(22):1418-21. PubMed ID: 2581135
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Sal synthase induced cytotoxicity of PC12 cells through production of the dopamine metabolites salsolinol and N-methyl-salsolinol.
    Xiong Q; Zheng X; Wang J; Chen Z; Deng Y; Zhong R; Wang J; Chen X
    J Integr Neurosci; 2022 Mar; 21(2):71. PubMed ID: 35364659
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.